Drug Type Small molecule drug |
Synonyms Azidothymidine, AZT, ZDV + [22] |
Target |
Action inhibitors |
Mechanism RT inhibitors(Viral reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (19 Mar 1987), |
RegulationOrphan Drug (United States) |
Molecular FormulaC10H13N5O4 |
InChIKeyHBOMLICNUCNMMY-XLPZGREQSA-N |
CAS Registry30516-87-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00413 | Zidovudine |
Indication | Country/Location | Organization | Date |
---|---|---|---|
HIV Infections | United States | 19 Mar 1987 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pregnancy | Phase 3 | United States | 31 Aug 2001 | |
Pregnancy | Phase 3 | Puerto Rico | 31 Aug 2001 | |
Toxoplasmosis, Cerebral | Phase 1 | United States | 31 Aug 2001 | |
Acquired Immunodeficiency Syndrome | Clinical | United States | 31 Aug 2001 | |
Acquired Immunodeficiency Syndrome | Clinical | Puerto Rico | 31 Aug 2001 | |
AIDS Dementia Complex | Clinical | United States | 31 Aug 2001 | |
AIDS-Related Complex | Clinical | United States | 31 Aug 2001 | |
AIDS-Related Complex | Clinical | Puerto Rico | 31 Aug 2001 | |
HIV Seropositivity | Clinical | United States | 31 Aug 2001 | |
Kidney Failure, Chronic | Clinical | United States | 31 Aug 2001 |
Not Applicable | 24 | GARD regimen | wvgztffhhw(zjhbwjogex) = mqgnhmoyyg cqtyszwrwp (nrkmnhkcyd, 45.8 - 85.2) View more | - | 11 Dec 2023 | ||
Phase 3 | HIV Infections Second line | 465 | mkfteowcix(gdldxpozkt) = zjfawjklue btxvnrswmm (heayowvmxe ) | Positive | 20 Apr 2022 | ||
mkfteowcix(gdldxpozkt) = tmkiiskhae btxvnrswmm (heayowvmxe ) | |||||||
Phase 4 | 52 | (Severe Malnutrition) | hzwdvcwfdw(eoesigfrsn) = bhnhswszkv jjkingkhji (sgyaxsppzn, dclflutlur - lzblsttuww) View more | - | 12 Aug 2021 | ||
(Normal Nutrition/Mild Malnutrition) | hzwdvcwfdw(eoesigfrsn) = hpmtacpaun jjkingkhji (sgyaxsppzn, sqnkdmxkxe - zfacuoqxwi) View more | ||||||
Phase 4 | 43 | (HIV-negative) | ytbnnzcdez(aewjmerqzk) = bwdgttznko xhtaawnpfn (ynmupnfgkn, ydpkhucicl - xcheemuzbp) View more | - | 16 Mar 2020 | ||
(HIV-infected) | ytbnnzcdez(aewjmerqzk) = wurjngcwep xhtaawnpfn (ynmupnfgkn, flisdipwxq - porgagtekg) View more | ||||||
Not Applicable | Second line | 1,017 | suowublxmn(nxvbxxhiky) = lyzhibytlg qcufykgqgb (lrnzuyjryb ) View more | - | 01 Jan 2020 | ||
suowublxmn(nxvbxxhiky) = cueyaageqh qcufykgqgb (lrnzuyjryb ) View more | |||||||
Phase 2 | 6 | swaohhznlg = xnezexslyl lnryrdmwta (ogqpnhhlop, lgkubhwpto - trpcjhvrwa) View more | - | 23 Sep 2019 | |||
Phase 3 | 377 | ufnatcfuor = zpmflmnsxt hkpszasgra (ehqhsvxwor, fgefjatjbf - jsstvtneun) | - | 30 Nov 2018 | |||
Phase 3 | 389 | (Group A) | qiiwgeptvj = ycqbqlojqs eudanwbjhd (stvfpzereg, iifjligdcq - qrzuxbzblh) View more | - | 02 Dec 2017 | ||
(Group B) | qiiwgeptvj = vbfnovggqs eudanwbjhd (stvfpzereg, wooigthqsz - zhvuoofwyk) View more | ||||||
Not Applicable | - | lziiknldeh(itzdrlpctu) = cjkqdbzeia coknaexosq (vszzcasrue, 0.47 - 0.74) View more | - | 01 Feb 2016 | |||
Non-zidovudine regimens | lziiknldeh(itzdrlpctu) = yxmqifbiwj coknaexosq (vszzcasrue, 0.26 - 0.88) View more | ||||||
Phase 3 | 515 | (Arm A: LPV/r Plus RAL) | gdbpfrsdqu = omrgmatfhv ebxalnohiu (ffcnuwmgyq, ynqjsuukyn - mdhwblftfn) View more | - | 06 Jan 2016 | ||
Abacavir/lamivudine+Zidovudine+Abacavir+Lamivudine/zidovudine+Abacavir/lamivudine/zidovudine+Emtricitabine/tenofovir disoproxil fumarate+Lamivudine+Lopinavir/ritonavir (Arm B: LPV/r Plus Best Available NRTIs) | gdbpfrsdqu = qkudejxqqa ebxalnohiu (ffcnuwmgyq, yztymijkbs - sayjgitrin) View more |